Age-Related Abdominal Fat Gain Linked to Leukemia Inhibitory Factor Receptor Activation

As individuals age, an increase in abdominal fat is a common concern, often attributed to lifestyle changes or a slowing metabolism. But, recent research from City of Hope, published in the journal Science, has identified a cellular mechanism responsible for this age-related waist widening. The study reveals that aging stimulates the emergence of a new type of adult stem cell in white adipose tissue, leading to increased production of fat cells, particularly around the abdomen.

The Role of Adipose Progenitor Cells and CP-As

Researchers, in collaboration with the University of California, Los Angeles, demonstrated that adipose progenitor cells (APCs) in the fat tissue of middle-aged and older individuals are not only more numerous but too possess an enhanced capacity to generate new fat cells. This process accelerates with age, differing from the behavior of other stem cells in the body. Specifically, the study identified a unique variant of these cells, termed Committed, age-specific preadipocytes (CP-As), which proliferate during midlife and directly contribute to increased abdominal fat.

Leukemia Inhibitory Factor Receptor (LIFR) Activation

A key finding of the research centers on the leukemia inhibitory factor receptor (LIFR). Activation of this receptor triggers the multiplication of these progenitor cells and their differentiation into fatty tissue, a process that becomes particularly prominent after middle age. This mechanism appears to be specific to abdominal white adipose tissue, explaining the concentration of fat accumulation in this area as people age.

Health Implications of Abdominal Fat Gain

Increased abdominal fat carries significant health risks beyond cosmetic concerns. Excess abdominal fat accelerates aging, reduces metabolism, and elevates the risk of developing type 2 diabetes and cardiovascular diseases, among other metabolic disorders. Even individuals who maintain a stable body weight can experience a loss of muscle mass and an increase in abdominal fat due to these cellular changes, as noted by Qiong (Annabel) Wang, a co-author of the study.

Implications for Future Therapies

The discovery of age-specific committed preadipocytes (CP-As) provides a new understanding of the relationship between aging and body fat distribution. Researchers emphasize that understanding these mechanisms could lead to the development of more personalized and effective strategies for preventing metabolic diseases related to age. Inhibiting or modulating the activity of the LIFR presents a potential strategy to block the formation of new fat cells and prevent abdominal obesity associated with aging.

Further research is focused on identifying signaling pathways that regulate the proliferation of CP-As, reinforcing the possibilities of future pharmacological interventions. The development of tools for early detection of changes in adipose progenitor cells could also allow for proactive risk assessment and personalized medical interventions.

Key Takeaways

• Aging stimulates the development of new stem cells in abdominal fat tissue.
• The leukemia inhibitory factor receptor (LIFR) plays a crucial role in the proliferation of these cells.
• Increased abdominal fat is linked to a higher risk of metabolic diseases.
• Targeting the LIFR pathway may offer a therapeutic avenue for preventing age-related abdominal obesity.

Controlling these cellular mechanisms represents a potential strategy to improve metabolic health and extend healthy life expectancy.